Vokanamet Canagliflozin Metformin: 7 Best Safety Checks

Vokanamet canagliflozin metformin 50/850 mg is a prescription combination tablet for adults with type 2 diabetes. It brings together canagliflozin, an SGLT2 inhibitor that helps the kidneys remove excess glucose in urine, and metformin, which reduces liver glucose production and improves insulin sensitivity. This guide explains the approved role, twice-daily administration, kidney checks and the seven safety points that matter most. It supports informed discussion with a clinician and does not replace an individual prescription.

Vokanamet canagliflozin metformin 50/850 mg at a glance

The medicine is an adjunct to diet and exercise. It may be prescribed when metformin alone is insufficient, together with other diabetes medicines, or as a replacement for separate canagliflozin and metformin tablets. It is not insulin, is not a weight-loss product and is not approved for type 1 diabetes.

How Vokanamet canagliflozin metformin works

Canagliflozin blocks sodium-glucose co-transporter 2 in the kidney. More glucose then leaves the body in urine, which lowers blood glucose independently of insulin. Metformin mainly reduces hepatic glucose production and improves how tissues respond to insulin. The complementary actions can improve glycaemic control, but the extra urinary glucose also explains effects such as more frequent urination, genital yeast infection and dehydration risk.

Your prescriber should individualise treatment according to current metformin exposure, glucose results, kidney function, age and other medicines. The official European Medicines Agency Vokanamet information provides the current authorised product documents. The official UK Vokanamet SmPC supplies additional prescribing detail. You can also browse the No Style Like English catalogue for related health products.

7 vital safety checks before and during treatment

1. Confirm that kidney function is suitable

Kidney function, reported as eGFR, should be checked before treatment and at least annually. Older adults and people whose kidney function may decline need more frequent monitoring. Vokanamet canagliflozin metformin must not be used in severe renal impairment with eGFR below 30 mL/min/1.73 m². A clinician may adjust or stop treatment at higher eGFR thresholds depending on the situation because both active ingredients depend on renal safety.

2. Prevent dehydration and low blood pressure

Canagliflozin increases urine output. Drink appropriate fluids unless your clinician has restricted them. Contact a healthcare professional if vomiting, diarrhoea, fever or poor intake causes dehydration. Treatment may need to be paused temporarily. Dizziness, faintness, intense thirst, dry mouth, weakness or very little urine can signal volume depletion. Extra care is required with diuretics, cardiovascular disease, low blood pressure, kidney impairment and older age.

3. Recognise diabetic ketoacidosis quickly

Diabetic ketoacidosis can occur even when glucose is only moderately raised. Stop the medicine and obtain urgent assessment for nausea, vomiting, abdominal pain, unusual thirst, difficult or deep breathing, confusion, severe fatigue or sleepiness. Blood ketone testing is preferred when ketoacidosis is suspected. Risk increases during serious illness, prolonged fasting, dehydration, reduced insulin, heavy alcohol intake or major surgery. Vokanamet is not suitable for type 1 diabetes.

4. Know the warning signs of lactic acidosis

Metformin-associated lactic acidosis is rare but life-threatening. Stop Vokanamet canagliflozin metformin and seek emergency help for acidotic or difficult breathing, abdominal pain, muscle cramps, profound weakness, reduced body temperature or a slow heartbeat. Risk rises with severe kidney or liver impairment, uncontrolled diabetes, acute serious illness, tissue hypoxia, dehydration and excessive alcohol use.

5. Plan surgery and contrast scans safely

Tell every clinician that you take this combination. It should be stopped for major surgery, prolonged fasting or serious acute illness and restarted only when the patient is stable. For iodinated contrast imaging, it must be withheld before or at the procedure and not restarted for at least 48 hours, after renal function has been checked and found stable. Following surgery, restart no earlier than 48 hours and only after oral nutrition and kidney function are satisfactory.

6. Protect the feet and treat infections early

Maintain preventive foot care and inspect the feet regularly, particularly with neuropathy or vascular disease. Contact a clinician promptly for ulcers, infection, bone infection, gangrene or new pain and colour change; interruption may be considered. Genital yeast infections are more common because urine contains glucose. Urgent care is needed for fever with urinary pain or back pain, or for genital/perineal pain, redness or swelling with fever or malaise, which may rarely indicate Fournier’s gangrene.

7. Review vitamin B12 and low-glucose risk

Long-term metformin can reduce vitamin B12. Testing may be appropriate with anaemia, neuropathy, dietary risk or other predisposing factors. Vokanamet alone has a low risk of hypoglycaemia, but the risk rises when it is combined with insulin or a sulfonylurea. A prescriber may reduce those doses. Carry a fast glucose source if advised and learn personal signs such as sweating, tremor, hunger, palpitations, confusion or blurred vision.

How to take Vokanamet canagliflozin metformin 50/850 mg

• Take one tablet twice daily with food if this is the regimen your prescriber selected.
• Swallow the film-coated tablet whole with water at consistent times.
• Do not split, crush or change the dose without medical advice.
• Continue the recommended meal plan, physical activity and glucose monitoring.
• If a dose is missed, take it when remembered unless the next dose is near. Never take two doses together.
• Seek urgent medical or poison-centre advice after an overdose; excess metformin can cause lactic acidosis.

The starting dose is normally chosen to provide canagliflozin 50 mg twice daily while maintaining the previous metformin amount. Some patients may later be considered for a higher canagliflozin strength, but only after clinical review of tolerance, kidney function and glucose control. A positive urine glucose test is expected because of canagliflozin and does not by itself mean treatment has failed.

Who should not take Vokanamet canagliflozin metformin?

Do not use it with allergy to either ingredient, severe renal failure, diabetic ketoacidosis or other acute metabolic acidosis, diabetic pre-coma, severe dehydration, shock, severe infection that threatens renal function, conditions causing tissue hypoxia, liver impairment, acute alcohol intoxication or alcoholism. Safety and efficacy have not been established for people under 18 years. Pregnancy, breastfeeding and planned pregnancy require prompt individual medical review.

Vokanamet canagliflozin metformin side effects and when to call

Common or clinically important effects include genital thrush, increased urination, thirst, gastrointestinal upset, reduced appetite and urinary infection. Starting with meals often improves metformin-related nausea or diarrhoea. Contact the prescriber if effects persist or glucose remains uncontrolled. Seek urgent care for ketoacidosis, lactic acidosis, severe dehydration, a serious allergic reaction, pyelonephritis or urosepsis, Fournier’s gangrene symptoms, or a new serious foot lesion.

Canagliflozin may interact with diuretics and medicines whose blood levels depend on kidney transport. Insulin and sulfonylureas increase hypoglycaemia risk. Avoid excessive alcohol. Always provide a full list of prescriptions, over-the-counter medicines and supplements before treatment changes.

Vokanamet canagliflozin metformin storage and pack checks

Store Vokanamet canagliflozin metformin below 30°C, dry, in its original closed container and out of children’s sight and reach. Do not use tablets after the expiry date or from a damaged, opened or tampered package. The Turkish 50/850 mg presentation is supplied as 60 film-coated tablets in a child-resistant container. Packaging can change, so verify the medicine name, strength, active ingredients, batch and expiry with a pharmacist.

Frequently asked questions

Is Vokanamet canagliflozin metformin the same as metformin?

No. It contains metformin plus canagliflozin. This gives complementary glucose-lowering actions and additional safety considerations, particularly kidney function, dehydration, genital infection and ketoacidosis.

Can I take it without food?

The authorised instructions recommend taking the tablet twice daily with meals. Food improves gastrointestinal tolerance and helps establish a consistent routine.

Does it cause glucose in the urine?

Yes. Canagliflozin is designed to increase urinary glucose excretion, so urine glucose tests will be positive. Blood tests such as HbA1c and clinician-directed monitoring are used to assess control.

Can I stop it during illness?

Acute dehydration, major surgery, prolonged fasting or serious illness may require a temporary pause, but contact a healthcare professional whenever possible. Urgent symptoms should never wait for routine advice.

Is this an online prescription?

No. This page is educational product information. Diagnosis, supply and dosing require an authorised prescriber and pharmacist according to local rules.

Vokanamet canagliflozin metformin medical disclaimer

This information summarises official product documents and does not replace the package leaflet, pharmacist advice or a clinician’s assessment. Dose, suitability, monitoring and restart after illness or procedures must be individualised. If emergency symptoms occur, stop the medicine when instructed above and obtain immediate medical help.